The potential of lipid emulsion for ocular delivery of lipophilic drugs.

For nearly a decade, oil-in-water lipid emulsions containing either anionic or cationic droplets have been recognized as an interesting and promising ocular topical delivery vehicle for lipophilic drugs. The aim of this review is to present the potential of lipid emulsions for ocular delivery of lipophilic drugs. The review covers an update on the state of the art of incorporating the lipophilic drugs, a brief description concerning the components and the classification of lipid emulsions. The ocular fate following topical instillation, safety evaluation experiments and the applications of lipid emulsions are thoroughly discussed.

[1]  S. Benita,et al.  Sequential statistical optimization of a positively-charged submicron emulsion of miconazole. , 1996, Pharmaceutical development and technology.

[2]  M. Orhan,et al.  Evaluation of Retinoic Acid Ophthalmic Emulsion in Dry Eye , 2000, European journal of ophthalmology.

[3]  S. Benita,et al.  Ocular delivery of cyclosporin A. II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A , 2001 .

[4]  T. Vandamme.  Microemulsions as ocular drug delivery systems: recent developments and future challenges , 2002, Progress in Retinal and Eye Research.

[5]  D. Mcclements,et al.  Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes. , 2003, Journal of agricultural and food chemistry.

[6]  G. Rieger.  Lipid-containing eye drops: a step closer to natural tears. , 1990, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[7]  J. Castell,et al.  In vitro methods in pharmaceutical research , 1997 .

[8]  P. Edman.  Biopharmaceutics of Ocular Drug Delivery , 1992 .

[9]  M. Lance,et al.  Structure and toxicity of amphotericin B/triglyceride emulsion formulations. , 1995, The Journal of antimicrobial chemotherapy.

[10]  S. Janicki,et al.  Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle. , 1999, International journal of pharmaceutics.

[11]  J. Aiache,et al.  The Formulation of Drug for Ocular Administration , 1997, Journal of biomaterials applications.

[12]  Rosemarie Osborne,et al.  Development and Intralaboratory Evaluation of an in Vitro Human Cell-Based Test to Aid Ocular Irritancy Assessments , 1995 .

[13]  F. E. Freeberg,et al.  Human and rabbit eye responses to chemical insult. , 1986 .

[14]  H. Sasaki,et al.  Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.

[15]  S. Benita,et al.  A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  A. Urtti,et al.  Evaluation of Cytotoxicity of Various Ophthalmic Drugs, Eye Drop Excipients and Cyclodextrins in an Immortalized Human Corneal Epithelial Cell Line , 1998, Pharmaceutical Research.

[17]  A. Baszkin,et al.  The stability of piroxicam incorporated in a positively-charged submicron emulsion for ocular administration , 1996 .

[18]  S. Benita,et al.  Enhanced absorption and drug targeting by positively charged submicron emulsions , 2000 .

[19]  V. H. Lee.  Precorneal, corneal, and postcorneal factors , 1993 .

[20]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[21]  C. Baudouin,et al.  Cytofluorimétrie sur empreintes conjonctivales au cours de la kératoconjonctivite sèche: effets de la ciclosporine topique sur l'expression d'antigène HLA DR , 2003 .

[22]  J. Lang.  Ocular drug delivery conventional ocular formulations , 1995 .

[23]  I. Kaur,et al.  Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery , 2002, Drug development and industrial pharmacy.

[24]  B. Reis,et al.  Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial☆ , 2000 .

[25]  R. Müller,et al.  Intravenous itraconazole emulsions produced by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  T. F. Patton,et al.  Importance of the noncorneal absorption route in topical ophthalmic drug delivery. , 1985, Investigative ophthalmology & visual science.

[27]  M. Sznitowska,et al.  Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  John W. Shell.  Ophthalmic drug delivery systems , 1984 .

[29]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[30]  M. Sznitowska,et al.  Increased partitioning of pilocarpine to the oily phase of submicron emulsion does not result in improved ocular bioavailability. , 2000, International journal of pharmaceutics.

[31]  Surajit Dey,et al.  Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies , 2003, Expert opinion on biological therapy.

[32]  M. Alonso,et al.  Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers , 1996, The Journal of pharmacy and pharmacology.

[33]  S. Benita,et al.  Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. , 1994, Journal of ocular pharmacology.

[34]  J. Salager,et al.  Pharmaceutical Emulsions and Suspensions , 2000 .

[35]  R. Gurny,et al.  Cyclosporine A delivery to the eye: a pharmaceutical challenge. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  B. Müller,et al.  Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process. , 1999, International journal of pharmaceutics.

[37]  M. Alonso,et al.  Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions , 1997 .

[38]  B. Reis,et al.  Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease1 , 2000 .

[39]  S. Benita,et al.  Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea , 1997 .

[40]  C. Baudouin,et al.  Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. , 2001, Investigative ophthalmology & visual science.

[41]  M. Sznitowska,et al.  Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[42]  G. Chader,et al.  PHARMACOLOGY OF THE EYE , 1984, Handbook of Experimental Pharmacology.

[43]  D. Monti,et al.  Ophthalmic emulsions and suspensions , 2001 .

[44]  W. Feuer,et al.  Interleukin-6 Levels in the Conjunctival Epithelium of Patients with Dry Eye Disease Treated with Cyclosporine Ophthalmic Emulsion , 2000, Cornea.

[45]  S. Benita,et al.  Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle , 1994, The Journal of pharmacy and pharmacology.

[46]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[47]  D. Brossard,et al.  Amphotericin B eye drops as a lipidic emulsion , 1996 .

[48]  B. Müller,et al.  In vitro investigation of the effect of various isotonic substances in parenteral emulsions on human erythrocytes. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  S. Almog,et al.  A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. , 1992, Ophthalmic research.

[50]  S. Benita,et al.  Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution , 2000, Pharmaceutical development and technology.

[51]  I. Gipson,et al.  Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. , 2000, Archives of ophthalmology.

[52]  S. Ding,et al.  Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. , 1999, Current eye research.

[53]  H Spielmann,et al.  The EC/HO international validation study on alternatives to the draize eye irritation test. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[54]  Deshpande,et al.  Ocular drug delivery in veterinary medicine. , 1997, Advanced drug delivery reviews.

[55]  D. Tang-Liu,et al.  Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. , 1990, Current eye research.

[56]  B. Reis,et al.  Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease. , 2002, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[57]  Indu Pal Kaur,et al.  Ocular Preparations: The Formulation Approach , 2002, Drug development and industrial pharmacy.

[58]  S. Benita,et al.  Emulsions as drug carriers for ophthalmic use , 1994 .

[59]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[60]  S. Benita,et al.  Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[61]  R. Müller,et al.  Formulation of intravenous carbamazepine emulsions by SolEmuls technology. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[62]  Michael E. Stern,et al.  Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3 , 2002, Advances in Experimental Medicine and Biology.

[63]  B. Müller,et al.  The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions , 1998 .

[64]  F. Nielloud,et al.  Emulsions in Health Care Applications—An Overview , 2002 .

[65]  M. Alonso,et al.  Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. , 1996, Journal of pharmaceutical sciences.

[66]  John H. Draize,et al.  METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .

[67]  Shulin Ding.  RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[68]  J F Griffith,et al.  Dose-response studies with chemical irritants in the albino rabbit eye as a basis for selecting optimum testing conditions for predicting hazard to the human eye. , 1980, Toxicology and applied pharmacology.

[69]  F. Behar-Cohen.  [Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications]. , 2002, Journal francais d'ophtalmologie.

[70]  A. Wiese,et al.  Preclinical safety studies of cyclosporine ophthalmic emulsion. , 1998, Advances in experimental medicine and biology.